In order to become a participant in the study, you should fill in and submit an application form.
Fill in application form
You can withdraw the data you provided at any time and refuse to participate in the bioequivalence studies of drugs.
Information on research participation
Dear candidate for participation in bioequivalence studies!
The National Anti-Doping Laboratory invites volunteers to participate in bioequivalence studies of drugs that will be conducted at out facility. The bioequivalence study is a comparative study of two drugs produced by different companies and having the same pharmaceutical substance. Studies are carried out only after program approval by the Ministry of Health of the Republic of Belarus and by the ethics committee. For participation in the study, the volunteer receives payment. Payment amount depends on the studied drug and duration of the study and is determined before the start of each study. Detailed information about the study and a description of the possible risks are provided to volunteers in advance. Only after reading and signing the informed consent document, the volunteer can take part in the study.
Basic study procedures
Before being included in the study, a volunteer will be screened at our facility. Studies can take place both at weekdays or weekends. A volunteer is hospitalized for 1-2 days (usually night-day-night). Volunteers are provided with food three times a day and stay under medical supervision. Food, medical examination, staying in the research center are free. During the study, a drug is usually taken once in a standard therapeutic dose (1 tablet). After that blood is drawn at regular intervals (18-25 times during the day). Blood loss is about 250 ml. A week later, the whole procedure is repeated. The total blood loss during the study is about 500 ml (for comparison, the standard blood loss for donation is 450 ml). A volunteer may refuse to participate in the study at any stage.
Who can become a study participant (volunteer)?
If you are over 18 and you are healthy, you may be a potential participant in the study as a volunteer.
You can not be a participant in the study if:
- You have a chronic illness, an allergy to drugs, or severe food allergy;
- You are constantly taking medicines;
- You abuse alcohol, take narcotic drugs, actively smoke;
- You are planning a pregnancy, are already pregnant, or breastfeeding.
What is the use of volunteer participation in the study?
For participation in the study, the volunteer receives payment. Payment amount depends on the studied drug and duration of the study and is determined before the start of each study.
During the study, you will be able to get more complete information about your health as a result of examinations and medical tests (complete blood count and urinalysis, blood test, electrocardiogram, screening for HIV, hepatitis B and C).
The study results will be useful for people receiving therapy with this drug.
Where will the study be conducted?
The study will be conducted at Clinical Trials Department of the National Anti-Doping Laboratory, which is located in the Republican Clinical Hospital for Disabled Great Patriotic War Veterans named after P.M.Masherov at the address: Minsk District, ag. Lesnoy, 5th floor of the medical building №2 (Borovlyany).
How long is participation in the study?
Duration of the study depends on the drug, the frequency of blood sampling and other reasons. Most often, a volunteer stays in the hospital for 1-2 days (usually night-day-night). In some cases, additional outpatient visits (without stay in a hospital) are possible. Studies can take place both at weekdays or weekends.
Can I participate in several studies?
You cannot participate in several studies at the same time. If you want, you can take part in the next study no earlier than 1-3 months after the end of previous study.
What are the health risks of participating in the study?
Prior to the study, a volunteer will get detailed information about the drug, its side effects and possible risks of the study. The drug is usually taken in a standard therapeutic dose. Information about possible risks and side effects is known, described in the medication package insert and provided in full to a volunteer before signing the informed consent. Prior to the start of the study, investigator will answer all your questions so you will be able to make an informed decision on participating in the study.
Every bioequivalence study is carried out only with the permission of the Ministry of Health of the Republic of Belarus and by the ethics committee.
During the study, you will be in a hospital under medical supervision.
Can I stop participating in the study after my agreement to participate in it?
You can stop your participation in the study at any time at your own request or for objective reasons beyond your control. The participation payment will be paid in proportion to your participation time in the study.